838 related articles for article (PubMed ID: 22044456)
41. Paclitaxel nanoparticle inhibits growth of ovarian cancer xenografts and enhances lymphatic targeting.
Lu H; Li B; Kang Y; Jiang W; Huang Q; Chen Q; Li L; Xu C
Cancer Chemother Pharmacol; 2007 Feb; 59(2):175-81. PubMed ID: 16718469
[TBL] [Abstract][Full Text] [Related]
42. Systemic delivery of micelles loading with paclitaxel using N-succinyl-palmitoyl-chitosan decorated with cRGDyK peptide to inhibit non-small-cell lung cancer.
Yuan ZQ; Li JZ; Liu Y; Chen WL; Yang SD; Zhang CG; Zhu WJ; Zhou XF; Liu C; Zhang XN
Int J Pharm; 2015 Aug; 492(1-2):141-51. PubMed ID: 26188316
[TBL] [Abstract][Full Text] [Related]
43. Self-aggregated nanoparticles of linoleic acid-modified glycol chitosan conjugate as delivery vehicles for paclitaxel: preparation, characterization and evaluation.
Yu J; Liu Y; Zhang L; Zhao J; Ren J; Zhang L; Jin Y
J Biomater Sci Polym Ed; 2015; 26(18):1475-89. PubMed ID: 26489688
[TBL] [Abstract][Full Text] [Related]
44. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma.
Shi L; Tang C; Yin C
Biomaterials; 2012 Oct; 33(30):7594-604. PubMed ID: 22796165
[TBL] [Abstract][Full Text] [Related]
45. Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel.
Wang B; Lv L; Wang Z; Jiang Y; Lv W; Liu X; Wang Z; Zhao Y; Xin H; Xu Q
Sci Rep; 2015 Nov; 5():16589. PubMed ID: 26567528
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug.
Huo M; Zhang Y; Zhou J; Zou A; Yu D; Wu Y; Li J; Li H
Int J Pharm; 2010 Jul; 394(1-2):162-73. PubMed ID: 20457237
[TBL] [Abstract][Full Text] [Related]
47. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
48. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study.
Zabaleta V; Ponchel G; Salman H; Agüeros M; Vauthier C; Irache JM
Eur J Pharm Biopharm; 2012 Aug; 81(3):514-23. PubMed ID: 22516136
[TBL] [Abstract][Full Text] [Related]
49. Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.
Lv W; Cheng L; Li B
Chem Pharm Bull (Tokyo); 2015; 63(2):68-74. PubMed ID: 25451039
[TBL] [Abstract][Full Text] [Related]
50. Thermosensitive micelles-hydrogel hybrid system based on poloxamer 407 for localized delivery of paclitaxel.
Ju C; Sun J; Zi P; Jin X; Zhang C
J Pharm Sci; 2013 Aug; 102(8):2707-17. PubMed ID: 23839931
[TBL] [Abstract][Full Text] [Related]
51. Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma.
Pandey V; Gajbhiye KR; Soni V
Drug Deliv; 2015 Feb; 22(2):199-205. PubMed ID: 24467582
[TBL] [Abstract][Full Text] [Related]
52. Hydrophobically modified carboxymethyl chitosan nanoparticles targeted delivery of paclitaxel.
Sahu SK; Maiti S; Maiti TK; Ghosh SK; Pramanik P
J Drug Target; 2011 Feb; 19(2):104-13. PubMed ID: 20367067
[TBL] [Abstract][Full Text] [Related]
53. pH-Sensitive Biocompatible Nanoparticles of Paclitaxel-Conjugated Poly(styrene-co-maleic acid) for Anticancer Drug Delivery in Solid Tumors of Syngeneic Mice.
Dalela M; Shrivastav TG; Kharbanda S; Singh H
ACS Appl Mater Interfaces; 2015 Dec; 7(48):26530-48. PubMed ID: 26528585
[TBL] [Abstract][Full Text] [Related]
54. Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles.
Xin H; Sha X; Jiang X; Zhang W; Chen L; Fang X
Biomaterials; 2012 Nov; 33(32):8167-76. PubMed ID: 22889488
[TBL] [Abstract][Full Text] [Related]
55. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
56. A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer.
Jiménez-López J; El-Hammadi MM; Ortiz R; Cayero-Otero MD; Cabeza L; Perazzoli G; Martin-Banderas L; Baeyens JM; Prados J; Melguizo C
Pharmacol Res; 2019 Mar; 141():451-465. PubMed ID: 30634051
[TBL] [Abstract][Full Text] [Related]
57. Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier.
Ma Q; Li B; Yu Y; Zhang Y; Wu Y; Ren W; Zheng Y; He J; Xie Y; Song X; He G
Int J Pharm; 2013 Mar; 445(1-2):88-92. PubMed ID: 23376505
[TBL] [Abstract][Full Text] [Related]
58. Integrin-facilitated transcytosis for enhanced penetration of advanced gliomas by poly(trimethylene carbonate)-based nanoparticles encapsulating paclitaxel.
Jiang X; Sha X; Xin H; Xu X; Gu J; Xia W; Chen S; Xie Y; Chen L; Chen Y; Fang X
Biomaterials; 2013 Apr; 34(12):2969-79. PubMed ID: 23380351
[TBL] [Abstract][Full Text] [Related]
59. Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring.
Kim K; Kim JH; Park H; Kim YS; Park K; Nam H; Lee S; Park JH; Park RW; Kim IS; Choi K; Kim SY; Park K; Kwon IC
J Control Release; 2010 Sep; 146(2):219-27. PubMed ID: 20403397
[TBL] [Abstract][Full Text] [Related]
60. [Preparation of paclitaxel-loaded chitosan polymeric micelles and influence of surface charges on their tissue biodistribution in mice].
Huo MR; Zhou JP; Wei Y; Lü L
Yao Xue Xue Bao; 2006 Sep; 41(9):867-72. PubMed ID: 17111835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
